Diversity, versatility and leukaemia / Geoffrey Brown and Isidro Sanchez-Garcia.

Format:

Book

Author/Creator:

Brown, Geoffrey, author.

Sanchez-Garcia, Isidro, author.

Series:

Cancer etiology, diagnosis, and treatments.

Cancer Etiology, Diagnosis and Treatments

Language:

English

Subjects (All):

Leukemia.

Blood cells.

Physical Description:

1 online resource (139 p.)

Place of Publication:

New York : Nova Biomedical, 2016.

Summary:

The blood cell system has provided a model system that has been used by many researchers to investigate how a stem cell can give rise to a wide variety of mature cell types. The principles that emerged in developmental biology have been applied to the structure of tissues throughout the body. However, many of the principles have been challenged by recent findings, changing the way we view blood cell development. In turn, this has impacted our understanding of the origin and nature of leukaemia, as well as cancer in general. Like the development of any body tissue, cancer is an organised and hierarchical tissue with its own identity. A new viewpoint is that the mutations that give rise to cancer re-programme cancer cells to their own abnormal pattern of tissue development. Understanding how the hierarchy of tumour identity differs from that of normal tissue provides important new avenues to the development of new treatments for cancer. No doubt further refinement to our understanding of normal and cancer cells will continue for many years to come. Even so, we appear to be moving towards an exciting prospect of providing the key to unlocking the long standing mystery of primary cellular events that undermine and distort our normal cells and give rise to the disease of cancer. The importance of this is the prospect of developing new treatments for cancer. In particular, the distorted behaviour of cancer cells might be reversible so that they can be restored to their normal state. Diversity, Versatility and Leukaemia examines how normal and cancer cells are inextricably linked, and focuses on the changes to how we view the development of normal cells and the subversion of this process in cancer.

Contents:

DIVERSITY, VERSATILITY AND LEUKAEMIA ; DIVERSITY, VERSATILITY AND LEUKAEMIA ; Library of Congress Cataloging-in-Publication Data; Contents ; Preface; Short Abstract; Acknowledgments; Chapter 1 The Diversity of Blood Cells ; Introduction; Red and Colourless Corpuscles; The Various Major Blood and Immune Cell Types; Innate Immune Cells - The Immediate Line of Defence; The Adaptive Immune System; Delineating Cell Lineages; Conclusion; References; Chapter 2 The Conventional Viewpoint to Hematopoiesis Introduction ; The Nature of Haematopoietic Stem Cells

Compartmentalisation of Developing Blood CellsTwo Families of Cells; A Single and Preferred Route to a Particular Cell Fate; Conclusion; References; Chapter 3 Revision to the Model of Haematopoiesis ; Introduction; Is There Just a Single Family of Blood Cells?; The True Nature of Haematopoietic Stem Cells; The Versatility of Developmental Pathways; Revising the Classic Model for Haematopoiesis; The Instructive Action of Haematopoietic Growth Factors; Conclusion; References; Chapter 4 Classifying the Various Leukaemias/Haematopoietic Cancers ; Introduction

Classification of Leukaemias/Haematopoietic Cancers Based on Histology and Cytological FeaturesImmunophenotype- and Genetic Abnormalities-Based Classifications of Leukaemias/Haematopoietic Cancers: Assignment of Human Haematopoietic Malignancy to Their Normal Cell Counterparts; Classification of Leukaemias/Haematopoietic Cancers Using New Technologies; Classification Using Gene Expression Profiling; Classification Using Next Generation Sequencing; Conclusion; References; Chapter 5 Leukaemia/Haematopoietic Cancer-Initiating Cellular Events ; Introduction; Treating Cancer

The Relevance of Oncogenes in Human CancerThe Influence of Oncogenes on Their Target Cell; The Cancer Stem Cell Theory; The Nature of the Cancer Cell-of-Origin; Conclusion; References; Chapter 6 Leukaemia/Haematopoietic Cancers and Lineage Commitment ; Introduction; The Concept of Cellular Reprogramming; Experimental Models of Tumoral Reprogramming; Tumoral Reprogramming: Therapeutic Evidences; P53 Is a Barrier to Tumoral Stem Cell Reprogramming; Fidelity of Tumour Lineage Conversion by Oncogenes and Epigenetic Memory; Conclusion; References

Chapter 7 The Prospect of New Treatments for Leukaemia and Other Cancers Introduction; Biology and the Treatment of Cancer; The Current Paradigm in Cancer Treatment; A New Paradigm: Cancer Stem Cells; Practical Implications of the CSC Hypothesis; The Nature of Epigenetic Signatures within Cells; Current Use of Epigenetic Modulators to Treat Cancer; Conclusion; References; Authors' Contact Information; Index

Notes:

Description based upon print version of record.

Includes bibliographical references at the end of each chapters and index.

Description based on print version record.

ISBN:

1-63484-795-4